Clinical Trial Update: Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing epinephrine and norepinephrine for efficacy and tolerability in cardiogenic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• EPINEPHRINE (EPINEPHRINE)
• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Cardiogenic Shock | Phase 4 | Status: COMPLETED